Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
VANCOUVER, Dec. 7, 2012 /CNW Telbec/ - Akela Pharma, Inc. (TSX: AKL) (the "Corporation") has announced that voluntary delisting of the Coproration's securities from the Toronto Stock Exchange (TSX)...
AUSTIN, TX, Feb. 6, 2012 /CNW Telbec/ - Akela Pharma, Inc. (TSX:AKL) and it's wholly owned subsidiary PharmaForm, a leader in pharmaceutical formulation and clinical manufacturing, today announced...
AUSTIN, TX, Dec. 16 /CNW Telbec/ - Akela Pharma, Inc. ("Akela"), (TSX: AKL), a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, a leader ...
AUSTIN, TX, Nov. 15 /CNW/ - Akela Pharma, Inc. ("Akela"), (TSX: AKL), a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm,...
AUSTIN, TX, Aug. 12 /CNW Telbec/ - Akela Pharma, Inc. ("Akela"), (TSX: AKL), a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary,...
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ QUEBEC, June 30 /CNW Telbec/ - Akela Pharma Inc. (("Akela Pharma") (TSX: AKL)) is pleased to...
In thousands of US dollars, unless specified otherwise AUSTIN, TX, June 18 /CNW Telbec/ - Akela Pharma, Inc. ("Akela"), (TSX: AKL), a leader in the development of therapeutics for the treatment of...
AUSTIN, TX, June 15 /CNW Telbec/ - Akela Pharma, Inc. ("Akela"), (TSX: AKL), a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary,...
AUSTIN, TX, May 31 /CNW Telbec/ - Akela Pharma, Inc. ("Akela"), (TSX: AKL), a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary,...
This AMENDED Press Release has been prepared and is being filed to correct, and is intended to replace in its entirely, a press release filed by Akela Pharma, Inc. on May 18, 2010 which inadvertently ...
AUSTIN, TX, May 18 /CNW Telbec/ - Akela Pharma, Inc. ("Akela"), (TSX: AKL), a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary,...
AUSTIN, TX, May 11 /CNW Telbec/ - Akela (TSX: AKL) a leader in the development of therapeutics for the treatment of pain and its wholly owned subsidiary, PharmaForm, a leader in the contract...
AUSTIN, TX, May 4 /CNW Telbec/ - Akela Pharma, Inc. ("Akela"), (TSX: AKL), a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary,...
AUSTIN, TX, April 19 /CNW Telbec/ - Akela Pharma, Inc. ("Akela"), (TSX: AKL), a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary,...
AUSTIN, TX, April 16 /CNW Telbec/ - Akela (TSX: AKL) a leader in the development of therapeutics for the treatment of pain and its wholly owned subsidiary, PharmaForm, a leader in the contract...
AUSTIN, TX, April 6 /CNW Telbec/ - Akela Pharma, Inc. ("Akela"), (TSX: AKL), a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary,...
AUSTIN, TX, March 19 /CNW Telbec/ - Akela Pharma, Inc., (TSX: AKL) a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today...
AUSTIN, TX, Feb. 19 /CNW Telbec/ - Akela Pharma, Inc., (TSX: AKL) a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today...
AUSTIN, TX, Feb. 4 /CNW Telbec/ - Akela (TSX: AKL) a leader in the development of therapeutics for the treatment of pain and its wholly owned subsidiary, PharmaForm, a leader in the contract...
www.akelapharma.com Toronto Stock Exchange Symbol: AKL </pre> <p/> <p><location>AUSTIN, TX</location>, <chron>Nov. 16</chron> /CNW Telbec/ - Akela...
Spray Dryer Strengthens PharmaForm's Portfolio of Bioavailability Enhancement Solutions AUSTIN, TX, Nov. 4 /CNW Telbec/ - PharmaForm, a contract pharmaceutical development and manufacturing ...
AUSTIN, TX, Oct. 20 /CNW Telbec/ - Akela Pharma, Inc., (TSX: AKL) a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.